+
Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

What are your goals for visiting NephU?(Required)
How would you like to hear from us?(Required)
Agree(Required)
This field is for validation purposes and should be left unchanged.

Archives

Loading Events

Mental Health In Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Thank you for attending, we hope you enjoyed this webinar.

Please tell us what you thought about today’s presentation by taking the survey below:

Mental Health In Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Background

  • The psychological impact of ADPKD can negatively impact the patient outcomes. Currently there is a paucity of research in this area and as a result, mental health is underrecognized and underdiagnosed in this patient population. Early detection and treatment of mental health can improve quality of life and is as important as medical management. Bringing awareness to this issue is critical to improving the management and overall well-being of these patients.
Did You Know?
  • Even early on in ADPKD, ADPKD patients report a lower satisfaction with life compared to healthy persons.1
Why Attend This Webinar?
  • The goal of this webinar is to increase awareness surrounding the emotional and physical burden that ADPKD patients face. The webinar will also discuss the impact on patient’s caregivers as well as the urgent call to action for collaborative engagement between nephrology and mental health experts to address mental health in ADPKD patients.
What You Will Learn
  • Discuss the psychological impact of ADPKD (i.e., the biological mechanisms behind anxiety and depression in ADPKD) as well as the emotional burden these patients face
  • Discuss the quality of life in ADPKD patients and the impact on family and caregivers
  • Evaluate the morbidity and mortality outcomes in ADPKD patients
  • Assess what HCPs can do better in terms of empowering their ADPKD patients and properly addressing their mental health needs
References:
  1. Yarlioglu, A.M., et al. Int Urol Nephrol. 2022 https://doi.org/10.1007/s11255-022-03375-2

Featuring

Rebecca S. Ahdoot

Rebecca S. Ahdoot, MD, FASN

Assistant Professor — Department of Nephrology

Director — PKD Partner Clinic at the UCI School of Medicine*

Dr Rebecca S. Ahdoot is a board-certified UCI Health nephrologist and director of the PKD Partner Clinic at UCI. She specializes in the management of acute and chronic kidney disease, hypertension/high blood pressure, kidney stones, electrolyte abnormalities and dialysis. She earned her medical degree at the UCI School of Medicine and completed an internal medicine residency at Kaiser Permanente Los Angeles Medical Center. She completed a joint neurology fellowship with Kaiser Permanente and Cedars-Sinai in Los Angeles. She also completed the UCLA Kennamer/Kaiser Permanente Community Medicine Fellowship program, which focuses on healthcare policy, patient advocacy and primary care. Dr Ahdoot is passionate about community service and outreach. She founded a bi-annual health fair to address the lack of affordable, timely vision and hearing services for low-income patients. She also has participated in volunteer medical missions to Guatemala through HELPS International.

Moderating

Marla Dallal

Marla Dallal, PharmD, RPH

Nephrology Senior Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Marla Dallal, PharmD, RPH is a Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization covering Southern California. She earned her Doctor of Pharmacy degree from the University of Southern California, School of Pharmacy in Los Angeles. While in pharmacy school, Dr Dallal pursued various clinical internships within the acute care and ambulatory care settings at Cedars-Sinai Medical Center and Kaiser Permanente. Prior to joining Otsuka, Dr Dallal held various positions within Medical Affairs at Amgen Inc covering the cardiometabolic and nephrology therapeutic areas. She also served as a preceptor at Amgen Inc, where she instructed pharmacy students on Advanced Pharmacy Practice rotations. She is currently licensed as a pharmacist in the state of California with the National Association Board of Pharmacy.

Jaimini Patel

Jaimini Patel, PharmD, BCCCP

Nephrology Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Jaimini Patel, PharmD, BCCCP, is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Patel earned her Doctorate in Pharmacy from the University of Michigan, Ann Arbor and completed two years of post-doctoral residency at Beaumont Hospital, Royal Oak and Loyola University Medical Center, respectively, specializing in critical care pharmacy practice. Prior to joining Otsuka, Dr Patel practiced as a critical care pharmacist at the Cleveland Clinic Akron General Medical Center for 3.5 years and has cared for patients in the medical, surgical/trauma, cardiothoracic and neuroscience ICUs, and was significantly involved in the care of patients with COVID-19. Dr Patel holds board certification in critical care pharmacotherapy and is a licensed pharmacist in Michigan, Illinois and Ohio. She is also an active member of the Society of Critical Care Medicine through which she is engaged in research and leadership.

*Dr Rebecca Ahdoot and Hannah Graves are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Marla Dallal and Jaimini Patel are employees of OPDC.

Registration

Related Resources

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.